Quality of life assessment and reporting in colorectal cancer: a systematic review of phase III trials published between 2012 and 2018

P Lombardi, L Marandino, E De Luca, C Zichi… - Critical reviews in …, 2020 - Elsevier
Background In this study, our aim was to describe quality of life (QoL) prevalence and
heterogeneity in QoL reporting in colorectal cancer phase III trials. Methods We included all …

Quality of life assessment and reporting in colorectal cancer: A systematic review of phase III trials published between 2012 and 2018

P Lombardi, L Marandino, E De Luca… - Critical reviews in …, 2020 - pubmed.ncbi.nlm.nih.gov
Background In this study, our aim was to describe quality of life (QoL) prevalence and
heterogeneity in QoL reporting in colorectal cancer phase III trials. Methods We included all …

Quality of life assessment and reporting in colorectal cancer: A systematic review of phase III trials published between 2012 and 2018

P Lombardi, L Marandino, E De Luca, C Zichi… - CRITICAL REVIEWS IN …, 2020 - iris.unito.it
Background: In this study, our aim was to describe quality of life (QoL) prevalence and
heterogeneity in QoL reporting in colorectal cancer phase III trials. Methods: We included all …

Quality of life assessment and reporting in colorectal cancer: A systematic review of phase III trials published between 2012 and 2018.

P Lombardi, L Marandino, E De Luca… - Critical Reviews in …, 2020 - europepmc.org
BACKGROUND: In this study, our aim was to describe quality of life (QoL) prevalence and
heterogeneity in QoL reporting in colorectal cancer phase III trials. METHODS: We included …